Platelet-Derived Growth Factor Preserves Retinal Synapses in a Rat Model of Ocular Hypertension. by Chong, Rachel S et al.
Glaucoma
Platelet-Derived Growth Factor Preserves Retinal Synapses
in a Rat Model of Ocular Hypertension
Rachel S. Chong,1–4 Andrew Osborne,4 Raquel Conceic¸a˜o,4 and Keith R. Martin4–7
1Singapore National Eye Centre, Singapore
2Singapore Eye Research Institute, Singapore
3Agency for Science, Technology and Research, Singapore
4John van Geest Centre for Brain Repair, University of Cambridge, Cambridge, United Kingdom
5Wellcome Trust Medical Research Council Cambridge Stem Cell Institute, Cambridge, United Kingdom
6Cambridge NIHR Biomedical Research Centre, Cambridge, United Kingdom
7Eye Department, Addenbrooke’s Hospital, Cambridge, United Kingdom
Correspondence: Keith R. Martin,
John van Geest Centre for Brain
Repair, University of Cambridge, E.D.
Adrian Building, Forvie Site, Robin-
son Way, Cambridge, CB2 0PY, UK;
krgm2@cam.ac.uk.
Submitted: August 3, 2015
Accepted: January 25, 2016
Citation: Chong RS, Osborne A, Con-
ceic¸a˜o R, Martin KR. Platelet-derived
growth factor preserves retinal syn-
apses in a rat model of ocular hyper-
tension. Invest Ophthalmol Vis Sci.
2016;57:842–852. DOI:10.1167/
iovs.15-17864
PURPOSE. Platelet-derived growth factor (PDGF) promotes neuronal survival in experimental
glaucoma and recruits glial cells that regulate synapses. We investigated the effects of
intravitreal PDGF on the inflammatory milieu and retinal synapses in the presence of raised
IOP.
METHODS. Animals with laser-induced IOP elevation received intravitreal injections of either
saline or 1.5 lg PDGF. At 7 days, a further intravitreal injection was administered so groups
received ‘‘PDGF–saline’’ (n ¼ 15), ‘‘PDGF–PDGF’’ (n ¼ 13), or ‘‘saline–saline’’ (n ¼ 20).
Platelet-derived growth factor receptor activation was assessed after 2 weeks using Western
blot for PI3 kinase. Immunohistochemistry was performed for markers of synapses in the
inner plexiform layer (IPL): PSD-95, GluR1, SY38; RGCs: bIII-tubulin, and glial cells: Iba-1,
CD45. Real-time quantitative polymerase chain reaction (qPCR) was performed for Arc, selp,
MCP-1, IL-6, IL-10, and CX3CR1 (n ¼ 13).
RESULTS. A single injection of PDGF increased IPL synaptic density in high IOP eyes (PSD-95 ¼
8.65 6 0.43, SY38 ¼ 8.68 6 0.51, GluR1 ¼ 9.03 6 0.60 puncta/lm3, P < 0.001) and
expression of synaptic modulator Arc (6.92 6 3.71-fold change/control, P < 0.05) in
comparison with vehicle (PSD-95 ¼ 4.59 6 0.41, SY38 ¼ 4.46 6 0.38, GluR1 ¼ 5.94 6 0.50
puncta/lm3, Arc ¼ 1.46 6 0.31-fold/control). This was associated with more resident
microglia (8.16 6 1.34-fold change/control, P < 0.001) and infiltrating monocyte-derived
macrophages in the retina as well as increased Selp expression (26.8 6 14.12-fold change/
control, P < 0.05). Optic nerve head (ONH) showed an increased microglia (saline ¼ 1.44 6
0.13 versus PDGF ¼ 2.23 6 0.18-fold change/control, P < 0.01) but not infiltrating
macrophages. IL-10 expression was significantly increased in PDGF-treated eyes (5.43 6 0.47-
fold change/control, P < 0.05) relative to vehicle (2.51 6 0.67-fold change/control).
CONCLUSIONS. Platelet-derived growth factor increased microglial and monocyte-derived
macrophage populations in the eye and protected intraretinal synapses from degeneration
in our experimental glaucoma model.
Keywords: synapses, macrophages, glaucoma posterior segment
Platelet-derived growth factor (PDGF) is an importantmediator of the neuroprotective effect of mesenchymal
stem cells on retinal ganglion cells (RGCs) in retinal explants as
well as in experimental glaucoma.1 Platelet-derived growth
factor also appears to enhance neuronal survival in a number of
other injury models including excitotoxicity2 and oxidative
stress.3
Platelet-derived growth factor may promote RGC survival
through a direct effect on the PI3 kinase/AKT pathway that
prevents cell death.4,5 However, it also is a potent chemo-
attractant and activator of inflammatory cells which modulate
neuronal health throughout the central nervous system (CNS).6–8
Platelet-derived growth factor has a particularly marked effect on
microglial proliferation and monocyte transmigration in the CNS
via monocyte-chemoattractant protein 1.9
Microglia regulate synapses in development and dis-
ease,10–12 via intimate contact between their filopodia and
dendritic spines in the CNS.13 Early microglial activation has
been noted in experimental models of glaucoma,14,15 while a
growing body of evidence also suggests that synaptic loss is an
initial feature of glaucoma that occurs before signs of RGC
death16,17 or changes to the dendritic structure18 are observed.
We have shown previously that intravitreally-administered
PDGF protects against loss of RGC bodies and axons in an
experimental model of glaucoma.1 However, effective RGC
neuroprotection also requires protection of the dendritic
compartment and the effect of PDGF on RGC dendrites and
synapses within the retina is unknown. Given the known
effects of PDGF on microglia and the role of microglia in
synaptic regulation in development and disease, we hypothe-
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sized that PDGF treatment may modulate the effect of IOP on
retinal dendrites and synapses in a rat model with raised IOP.
We measured RGC survival and dendrite health using bIII-
tubulin immunostaining, and analysed the retina for changes in
synaptic markers, such as postsynaptic density 95 (PSD-95),
glutamate receptor-1 (GluR1), as well as synaptophysin 38
(SY38). Microglia and monocyte-derived macrophage popula-
tions in the retina and optic nerve head (ONH) were assessed
based on Iba-1 and differential CD45 expression. Gene
expression of Arc, which regulates synapses in the CNS, the
chemokine receptor CX3CR1, and inflammatory cytokines IL-
10 and IL-6, also were measured with real time polymerase
chain reaction (qPCR).
We report for the first time to our knowledge that PDGF
protects intraretinal synapses and dendrites from degeneration
in eyes with experimental IOP elevation. These findings
provide insight into the neuroprotective effect of PDGF during
the initial stages of ocular hypertensive injury, which could
have important implications for the early detection and
treatment of this sight-threatening disease.
METHODS
Animals
A total of 48 animals were used for this study. Adult 275 to 360
g male Sprague Dawley rats were purchased from Charles River
(Margate, Kent, UK) and maintained in accordance with
guidelines set forth by the UK Home Office regulations for
the care and use of laboratory animals, the UK Animals
(Scientific Procedures) Act (1986), and the Association for
Research in Vision and Ophthalmology’s Statement for the Use
of Animals in Ophthalmic and Visual Research.
Experimental Ocular Hypertension Model. Raised IOP
(ocular hypertension [OHT]) was induced using a modification
of the method developed by Levkovitch-Verbin et al.19 Rats
were anesthetized with ketamine (50 mg/kg) and xylazine (10
mg/kg). Intraocular pressure was measured in both eyes using
the TonoLab rebound tonometer (ICare, Tiolat Oy, Finland)
within 5 minutes of the onset of anesthesia between the hours
of 9:00 and 11:30 AM to minimize the influence of diurnal
variation or general anesthesia on measured IOP.20
One eye was injected with 3 lL of 0.5 lg/lL; that is, 1.5 lg
PDGF-AB (#100-00AB; Peprotech, Rocky Hill, NJ, USA) or
sterile PBS (Sigma-Aldrich Corp., St. Louis, MO, USA) using a
30-gauge needle mounted on a 5 lL glass Hamilton syringe
(Hamilton Bonaduz AG, Bonaduz, Switzerland). Solutions for
injection were masked at the time of injection. The same eye
then underwent translimbal laser photocoagulation using a
diode laser (wavelength 532 nm, spot size 50 lm, power 700
mW, duration 600 ms). The fellow untreated eye was used as a
control.
Intraocular pressure of both eyes was rechecked 24 hours
after the laser procedure under general anesthesia as described
above, and again a week later. Animals with IOP of less than 20
mm Hg at 1 week following the initial laser treatment received
another round of translimbal laser photocoagulation to the
same eye. Animals also received a second intravitreal injection
at this point, and were divided into groups of ‘‘saline–saline’’
(saline, n¼ 20), ‘‘PDGF–saline’’ (PDGF3 1, n¼ 15) or ‘‘PDGF–
PDGF’’ (PDGF3 2, n¼ 13). Intraocular pressure was recorded
under general anesthesia the following day, 8 days after the first
laser treatment. At 2 weeks after the original procedure,
bilateral IOP was recorded again and the animals were culled
for tissue processing.
An additional set of control experiments was performed on
animals that received intravitreal saline injections without laser
photocoagulation (saline inj–no laser, n¼ 5), laser photocoag-
ulation without intravitreal injections (laser–no inj, n¼5), laser
photocoagulation with saline injections (laser with saline, n¼
6) and unlasered control eyes (control, n¼ 6) for immunohis-
tochemistry of retinal sections.
Immunohistochemistry
Retinal and Longitudinal ONH Sections. Eyes were
fixed with 4% paraformaldehyde for 30 minutes before being
transferred to 30% sucrose in PBS (control, n¼ 6; saline, n¼ 6;
PDGF3 1, n¼ 4; PDGF3 2, n¼ 4). Eyes then were immersed
in embedding capsules with the plica semilunaris perpendic-
ular to the plane of sectioning. Retina sections of 14 lm
thickness were collected through the dorsal-ventral/superior-
inferior axis of the retina.
Slides were blocked in 10% normal goat serum (NGS) in PBS
with 0.5% Triton X-100 for one hour at room temperature.
Primary antibodies made up in buffer solution of 4% NGS in
PBS with 0.3% Triton X-100 included antibodies against rabbit
bIII-tubulin (1:1000; Covance Research Products, Inc., Denver,
NJ, USA), mouse bIII-tubulin (1:2000; Promega, Madison, WI,
USA), mouse NeuN (1:250; EMD Millipore, Billerica, MA, USA),
mouse post-synaptic density protein 95 (PSD-95, 1:1000;
Abcam, Cambridge, UK), chicken synaptophysin (SY38,
1:1000; Abcam), rabbit glutamate receptor-1 (GluR1, 1:50;
Calbiochem, San Diego, CA, USA), guinea pig ionized calcium
binding adaptor protein 1 (Iba-1; 1:500; Synaptic Systems,
Go¨ttingen, Germany), rabbit phospho-PDGF receptor a
(pPDGFR, 1:50; Abcam), rabbit CD45 (1:300; Abcam). Alexa-
Fluor-conjugated secondary antibodies (1:1000; Invitrogen,
Carlsbad, CA, USA) then were added for one hour together
with 40,6-diamidino-2-phenylindole (DAPI) stain. Two slides
also were stained in the absence of each primary antibody for
use as negative controls.
Images were taken on a Leica SP5 confocal microscope at
340 and 363 magnification with z-step intervals of 0.3 lm.
Open-source image processing software Fiji21 was used to
reconstruct z-stack projections of individual optical sections
for quantification. Images for the quantification of synaptic
marker density in the inner plexiform layer (IPL) were taken
from six images per eye using 340 magnification at the area
bounded by the RGC layer (RGCL) and inner nuclear layer
(INL), with the stack end-points set to visualize 40,6-diamidino-
2-phenylendole (DAPI)–stained nuclei at the RGCL. Only
sections with the ONH clearly visible were chosen for analysis
to ensure that the regions being assessed were equidistant
from the ONH and along the superior–inferior axis, as far as
possible. This is important, as topographical studies of rodent
retinas have shown that the density of RGCs varies with
distance from the ONH.22 Confocal images were thresholded
to the average of five positively-staining synaptic puncta for
each channel, and counted using the automated Analyze
Particle plug-in on Fiji which measured the total number of
particles above the set threshold value. Only particles within
the area bounded by the RGCL and INL (the IPL area) were
counted. The z-stack volume was calculated by multiplying the
z-step size by the number of slices per stack and the IPL area
for each stack. The total particle count for all slices through the
stack then was divided by the z-stack volume to obtain the
synaptic density for each marker.
Retinal ganglion cell numbers were quantified based on the
numbers of bIII-tubulin and DAPI-positive cells within the RGC
layer. Retinal regions used in this analysis were equidistant
from the optic nerve head and taken from at least four
individual sections per eye. Tubulin fluorescent intensity
within the IPL also was assessed within this region by
measuring the fluorescent integrated density within at least
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eight 30 3 30 lm regions positioned between the RGCL and
INL.
Differential levels of CD45 expression can be used to
determine if Iba-1–positive cells are infiltrating monocytes
from the peripheral circulation, which show high levels of
CD45, or part of a resident microglial population that express
CD45 at low levels.23 Therefore, Iba-1–positive cells in retinal
sections also were assessed for levels of CD45-expression and
categorized as CD45hi or CD45lo based on the intensity of
staining.
Analysis of longitudinal ONH sections focused on the
laminar zone, which has been defined as a conical area
bordered by the posterior sclera proximally and the start of the
myelinated optic nerve distally.24,25
Whole Mounts and Transverse ONH Sections. Whole
mount retinas (control, n¼ 5; saline, n¼ 6; PDGF3 1, n¼ 4;
PDGF 3 2, n ¼ 2) were fixed in 4% paraformaldehyde and
blocked in 5% NGS, 0.2% BSA, and PBS with 0.3% Triton X-100
for 1 hour with gentle shaking at room temperature based on a
protocol suggested by Tual-Chalot et al. 2013.26 Blocking
solution then was replaced with primary antibodies (as above)
made up in the same buffer at 48C overnight and washed four
times, 10 minutes each, in PBS with 0.3% Triton X-100 at room
temperature. Secondary antibodies with DAPI were applied for
four hours at room temperature with gentle shaking, and then
washed four more times in PBS with 0.3% Triton X-100.
Confocal images of whole-mount retina Iba-1, bIII-tubulin,
and pPDGFR immunofluorescence were taken at 340 magni-
fication. Details of all treatment groups were masked at the
time of assessment.
Transverse optic nerve sections were obtained from scleral
cups after retinas had been removed for whole mount staining,
and processed in a similar manner to the longitudinal ONH
sections.
Real-Time qPCR Reaction
RNA was extracted from retinas (control, n¼ 4; saline, n¼ 5;
PDGF3 1, n¼ 4; PDGF3 2, n¼ 4) using the RNeasy Mini Kit
(Qiagen Ltd., Manchester, UK) with on-column DNase diges-
tion. Complementary DNA (CDNA) synthesis was performed
using the SuperScript III First-Strand synthesis Supermix kit
from Life Technologies, Inc. (Frederick, MD, USA). Taqman
Gene Expression Assay primer/probes were used with TaqMan
Fast Advanced Master Mix (both from Life Technologies, Inc.)
for qPCR. Gene expression assays for Arc (Rn00571208_g1),
Selp (Rn00565416_m1), MCP-1 (Rn00580555_m1), CX3CR1
(Rn02134446_s1) , IL -6 (Rn01410330_m1) , IL -10
(Rn00563409_m1), and GAPDH (Rn01775763_g1) were pur-
chased from Life Technologies, Inc. Between 30 and 50 ng
cDNA in 2 lL volume was used per reaction. The system was
programmed to run for 40 cycles at the following settings: 508C
for 2 minutes, 958C for 20 seconds, 958C for 3 seconds, and
608C for 30 seconds each, according to the suggested protocol
from Applied Biosystems (Foster City, CA, USA). GAPDH was
used as a reference gene, and the standard curve method was
used for relative quantification of gene expression.
Western Blotting
Retinas (control, saline, PDGF 3 1, PDGF 3 2; n ¼ 3) were
homogenized in complete lysis-M (Roche, Berlin, Germany)
containing protease inhibitor (Roche) and phosphatase inhib-
itor (Thermo Fisher Scientific, Grand Island, NY, USA). Protein
(10 lg) was loaded into 4-12% pre-cast gels (Life Technologies)
and electro-transferred to PVDF membranes (Life Technolo-
gies). Membranes were blocked in 5% dried skimmed milk in
PBS with 0.2% Tween20 (Sigma-Aldrich Corp.) for 1 hour and
incubated overnight with primary antibody in blocking
solution at 48C. Primary antibodies included PI3K (1:500; Cell
Signaling, Herts, UK) and b-actin (1:1000; Cell Signaling)
horseradish peroxidase (HRP) conjugated secondary antibod-
ies (1:10,000; Vector Laboratories Ltd., Peterborough, UK)
were used for 1 hour at 48C before signal detection using ECL
Prime (GE Healthcare, Amersham, UK) and an Alliance
Western blot imaging system (UVItec Ltd., Cambridge, UK).
Statistical Analysis
All data were expressed as mean 6 SEM. Differences in the
mean level of IOP and cumulative IOP exposure in control and
lasered eyes were tested for statistical significance using the
unpaired t-test. A 1-way ANOVA with Bonferroni’s multiple
comparison test was performed for all other statistical analyses
using Graphpad Prism v5.0b.
RESULTS
PDGF Increased IPL Synaptic Proteins and bIII-
Tubulin Levels in Eyes With IOP Elevation
Cumulative IOP exposure measured over 2 weeks was
significantly higher in eyes that received laser photocoagula-
tion than in control eyes (P < 0.0001): saline (lasered¼ 360 6
111.5, control ¼ 172.2 6 15.34 mm Hg.days), PDGF 3 1
(lasered¼ 396.1 6 139, control¼ 170.9 6 17.87 mm Hg.days),
PDGF 3 2 (lasered ¼ 439.6 6 125.3, control ¼ 174.1 6 21.64
mm Hg.days). No significant difference was found in IOP
measurements amongst all laser treated eyes. Sixty to 75% of
lasered eyes required subsequent re-treatment one week later,
consistent with numbers cited from previous studies.19 The
mean IOP of eyes that underwent laser photocoagulation was
higher than unlasered control eyes in all experimental groups
(Supplementary Fig. S1).
Analysis of positive immunostained synaptic puncta in the
IPL showed that the density of PSD-95, SY38, and GluR1
decreased with high IOP and saline injection (PSD-95¼ 4.59 6
0.41, SY38 ¼ 4.46 6 0.38, GluR1 ¼ 5.94 6 0.50 puncta per
lm3), compared to control eyes (PSD-95¼ 10.57 6 0.66, SY38
¼ 7.46 6 0.28, GluR1¼ 14.36 6 1.27 puncta per lm3; Fig. 1).
However, eyes that had high IOP which were injected with
PDGF showed a statistically significant increase in the levels of
all 3 synaptic markers compared to the high IOP and saline
injection group (PDGF3 1: PSD-95¼ 8.65 6 0.43, SY38¼ 8.68
6 0.51, GluR1¼9.03 6 0.60; PDGF32: PSD-95¼9.56 6 0.61,
SY38 ¼ 7.31 6 0.39, GluR1 ¼ 11.84 6 0.60 puncta per lm3;
Fig. 1). Immunohistochemical images for PDGF3 1 have been
omitted from the Figures due to space constraints.
Arc, which encodes the activity-regulated cytoskeleton-
associated protein, is an immediate early gene that is involved
closely with modulating synaptic changes in the central
nervous system.27–29 A significant increase in Arc mRNA was
observed in eyes with high IOP following PDGF 3 1
administration (6.92 6 3.71-fold/control) in comparison with
the saline group (1.46 6 0.31-fold/control). Two treatments of
PDGF in hypertensive eyes showed only a modest effect on Arc
mRNA (2.69 6 0.50-fold/control), although synaptic density in
the IPL was comparable to the levels detected with PDGF3 1.
Changes in synaptic density were not a result of a difference
in RGC survival between groups as no significant decrease was
detected in the number of bIII-tubulin–positive RGCL cells at 2
weeks after laser-induced OHT (Fig. 2). However, the intensity
of bIII-tubulin was significantly decreased in the IPL of eyes
with elevated IOP that received only saline injections (0.71 6
0.02-fold/control versus PDGF 3 1 ¼ 1.04 6 0.08, PDGFX2 ¼
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0.95 6 0.05-fold/control; Fig. 2) indicating a possible loss of
RGC dendrites that occurred before cell death.
Animals that received intravitreal injections of saline alone
without laser photocoagulation did not show any significant
difference from unlasered control eyes, while intravitreal
injections of saline with laser photocoagulation showed a
similar effect as laser photocoagulation alone (Supplementary
Fig. S2) suggesting that saline alone did not contribute to the
observed synaptic changes.
Activated PDGF Receptor Strongly Colocalized
With Iba-1þ Cells in the Retina
Immunohistochemical analysis of whole mount and sectioned
retinas revealed only moderate colabeling of p-PDGFR with the
RGC markers bIII-tubulin and NeuN (Fig. 3). However, strong
colocalization was noted between Iba-1–positive cells and
activated PDGF receptors. This was particularly marked in eyes
with ocular hypertension, which showed high numbers of Iba-
1–positive cells (Fig. 4).
The PI3K pathway, which has an important role in PDGF-
mediated neuroprotection,1 was significantly increased after
two doses of intravitreal PDGF (0.76 6 0.07 OD) relative to
control (0.43 6 0.05 OD) or saline (0.36 6 0.02 OD) groups. A
single injection of PDGF also showed an increase in signaling
activity (0.67 6 0.12 OD) although this did not reach statistical
significance.
Effect of PDGF on the Inflammatory Milieu Within
the Retina and Optic Nerve
Differential CD45 expression has been used previously to
distinguish between infiltrating monocytes and resident
microglial populations.23,30 To validate this distinction in the
eye, a longitudinal section through a normal optic nerve and
adjacent posterior ciliary vessel was stained for CD45 and Iba-1
(Supplementary Fig. S3). This showed intense expression of
CD45 on circulating monocytes in the blood vessel (CD45hi),
while CD45 immunostaining was only minimally present in
Iba-1–positive myeloid cells within the optic nerve (CD45lo).
Platelet-derived growth factor–treated ocular hypertensive
eyes had increased numbers of Iba-1þ/CD45lo (PDGF 3 1 ¼
8.16 6 1.34, PDGF3 2¼ 5.16 6 1.11-fold change/control) and
Iba1þ/CD45hi cells in the retina, relative to eyes with elevated
IOP that had only received saline injections (1.61 6 0.35-fold
change/control; Fig. 4). The increase in Iba-1þ/CD45hi cells
FIGURE 1. (A–D) Ocular hypertensive eyes (OHT) that received saline injections showed a decrease in synaptic proteins PSD-95, GluR1, and SY38
in the IPL relative to control. However, OHT eyes that had been treated with PDGF showed a significant increase in these proteins in comparison
with vehicle-injected eyes. (E) mRNA levels of Arc were significantly elevated in eyes with high IOP that had been treated with one injection of
PDGF. A 1-way ANOVA was performed for PDGF-treated against saline-only eyes. **P < 0.01, ***P < 0.001. Error bars: SEM.
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with PDGF injections was much higher (saline ¼ 2.67 6 0.73
versus PDGF 3 1 ¼ 29.44 6 2.78, PDGF 3 2 ¼ 26.56 6 6.56-
fold change/control) in comparison with the changes seen in
Iba-1þ/CD45lo cells.
Real-time PCR analysis of Selp, which codes for p-selectin,
also was elevated in the retina of eyes that had received single
PDGF injections (26.8 6 14.12-fold change/control) in
comparison with saline-injected eyes (2.89 6 1.07-fold
change/control). Expression of monocyte chemoattractant
protein-1 (MCP-1) showed a very similar trend in eyes with
single PDGF (6.43 6 1.52-fold change/control) injections in
comparison with saline-injected eyes (1.52 6 0.27)-fold
change/control). Eyes that were injected with PDGF twice
showed higher levels of both selp and MCP-1, although this did
not reach statistical significance (9.41 6 5.70 and 3.65 6 0.39-
fold change/control, respectively). Both P-selectin and MCP-1
have important roles in mediating monocyte transmigration
through blood vessels,31,32 providing further support for the
increased numbers of Iba-1þ/CD45hi cells that were detected
in retinas of OHT eyes treated with PDGF.
Examination of the ONH showed an increase in only Iba1þ/
CD45lo (saline¼ 1.44 6 0.13 versus PDGF3 1¼ 2.23 6 0.18,
PDGF 3 2 ¼ 2.18 6 0.15-fold change/control; Fig. 5) but not
Iba1þ/CD45hi cells under similar conditions (data not shown).
PDGF Alters Inflammatory Cytokine Production in
the Retina
Real-time PCR analysis of retinal tissues detected an increase in
the microglial marker CX3CR1 in PDGF-treated eyes relative to
saline-injected eyes with high IOP, which may be related to the
increased numbers of microglia and monocytes detected in the
retina, although this did not reach statistical significance (Fig.
6). Expression of the anti-inflammatory cytokine IL-10 also was
higher in ocular hypertensive eyes that received PDGF
injections (PDGF 3 1 ¼ 5.43 6 0.47, PDGF 3 2 ¼ 4.88 6
1.31-fold change/control) compared to saline (2.51 6 0.67-fold
change/control), while the reverse trend was noted with IL-6
(saline¼12.51 6 3.45 versus PDGF31¼5.40 6 1.80, PDGF3
2 ¼ 5.78 6 2.24-fold change/control).
DISCUSSION
Platelet-derived growth factor has been demonstrated previ-
ously to provide robust axonal protection and prevent cell
death in RGCs using an experimental model of ocular
hypertension.1 The results of our study provided new evidence
that PDGF may promote RGC dendrite health and synaptic
FIGURE 2. (A) Platelet-derived growth factor prevented the loss of bIII-tubulin staining in the inner plexiform layer of eyes with elevated IOP. (B)
Eyes that were injected with saline showed a significant decrease in bIII-tubulin intensity in the IPL compared to control, while eyes that received
PDGF treatment did not. (C) No loss of RGC cell number was seen 2 weeks after elevated IOP in any of the groups. **P < 0.01.
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density in ocular hypertensive eyes. These changes appear to
be associated with marked alterations in the inflammatory cell
populations within the retinal and optic nerve head, which
could facilitate neuron-glia interactions that help to mediate
this neuroprotective effect.
Changes to RGC synapses and dendrites are thought to be
early events in experimental glaucoma.18,33 Our study supports
these findings where reductions in postsynaptic density
markers PSD-95 and GluR1 as well as the synaptic vesicle-
associated protein SY38 were found in eyes with elevated IOP.
Interestingly, treatment with PDGF resulted in significantly
higher levels of all 3 synaptic proteins as well as the immediate
early gene Arc, which has an active role in modulating
dendritic structure and function as well as synaptic plastici-
ty.27–29 As the majority of ocular hypertensive eyes were
subjected to two consecutive lasers in each treatment group,
varying exposure to laser photocoagulation alone is unlikely to
account for the significant differences in experimental
outcomes. Two injections of PDGF appeared to result in lower
Arc expression than a single dose, although a possible
explanation for this discrepant effect could be feedback
downregulation of gene expression. Our observations that
twice as much PDGF administration appeared to result in
downregulation of Selp and MCP-1 also may be related to the
heightened production of matrix metalloproteinases and
fibroblast growth factor-2, which have been shown to reduce
transendothelial cell migration.34–36 Further studies must be
conducted to verify this.
Whether PDGF directly influences the synaptodendritic
compartment of RGCs, or if it acts through an intermediary
cell-type remains unclear. An earlier study demonstrated that
PDGF increases Arc expression in cortical neurons via Egr-1
activation from the MAPK/ERK pathway37 suggesting that
PDGF could have a similar direct effect on RGCs. This could be
related to the increased retinal activation of PI3K induced by
PDGF observed in our experiments. A pertinent finding of our
study was that PDGF treatment also caused marked changes in
resident microglial (Iba-1/CD45lo) as well as infiltrating
monocyte-derived macrophage (Iba-1/CD45hi) populations in
the eye. These findings support results from Bethel-Brown et
al.,7 who showed that PDGF is a potent chemoattractor for
monocytes via MCP-1 signaling. Platelet-derived growth factor
receptor a has been found on monocytes and macrophages
within the CNS,38,39 and prominently colocalized with Iba-1
cells in the retina following intravitreal PDGF injections in our
study. This raises the intriguing possibility of an association
between PDGF-induced alterations in microglial/macrophagic
activity and synaptic plasticity in our experiments. Further-
more, the site-specific differences that we noted in the
microglial response to PDGF at the retina and ONH may be
FIGURE 3. Phosphorylated PDGF receptor (teal) showed only moderate costaining with RGC markers bIII-tubulin and NeuN (green) in retinal
wholemounts (A) and sections (B), while intense colocalization was noted with Iba-1 positive cells (red). (C, D) PI3K signaling was increased in
eyes that received PDGF injections, in comparison with control and saline-injected eyes. *P < 0.05.
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relevant to the mechanism of action of PDGF as the
recruitment of leukocytes is believed to be largely confined
to postcapillary endothelium in the ganglion cell, nerve fiber
and inner nuclear layers.40,41 This would suggest that the
synapse preserving effect of PDGF is largely confined to the
retina, and unlikely to involve larger vessels at the ONH.
There is strong evidence of an association between
microglial activation and RGC loss in experimental glaucoma.
Inactivation of microglia appears to have a beneficial effect on
RGC survival,42 while deficiencies in fractalkine, which
normally inhibits microglial activity, produce the converse
outcome of exacerbating RGC death instead.43 Interestingly,
however, enhanced neuroprotection has been demonstrated in
parallel with increased numbers of Iba-1–positive cells in the
retina, following intravitreal injections of ciliary neurotrophic
factor (CNTF) or hepatocyte growth factor (HGF) after optic
nerve transection.44 These findings support our own observa-
tions with PDGF treatment in an OHT model of glaucoma. It is
clear that further research into characterizing the inflammatory
profiles of different optic nerve injury models is necessary to
deepen our understanding of how this influences neuron-glia
interactions.
Our results also are in keeping with a study by London et
al.45 who elegantly demonstrated that enhancing the infiltra-
tion of monocyte-derived macrophages into glutamate-intoxi-
cated retinas resulted in a switch in the behavior of the local
FIGURE 4. (A) Ocular hypertensive eyes that were injected with PDGF showed an increase in Iba-1þ/CD45hi (bright green) (B) and Iba-1þ (red) /
CD45lo (light green) (C) cell populations in the retina. We used DAPI to stain cell nuclei (blue). QPCR of retinal tissue for MCP-1 (D) and the p-
selectin gene selp (E) also were shown to be higher in PDGF-treated eyes than saline only eyes with high IOP. *P < 0.05, **P < 0.01, ***P < 0.001.
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inflammatory milieu from a proinflammatory to an anti-
inflammatory state. This effect was at least partially dependent
on IL-10 production, which also was increased in our
experimental groups that received PDGF treatment. Further-
more, IL-10 has been suggested to have a dominant role in
microglia-induced synaptic remodeling,46 which could provide
additional support for our findings. This contrasts with a
previous study where radiation treatment was suggested to be
neuroprotective in the DBA/2J mouse model of glaucoma, due
to the elimination of monocytic transmigration into the optic
nerve head.30 However, a subsequent study that examined a rat
model of ocular hypertension found that there was no
difference in RGC survival or Iba-1 cell density following
ocular radiation.47 The same study also reported an absence of
monocyte entry into the ONH with elevated IOP, consistent
with our results.
Microglia are believed to be intimately involved in the
modulation of synaptic density in physiological and pathologic
states in the CNS,13,16 although to our knowledge ours is the
first study to show that higher numbers of microglia and
monocyte-derived macrophages may be associated with
increased synaptic density within the retina. Microglia48 and
monocytes49 produce high levels of brain-derived neurotroph-
ic factor (BDNF), which is known to be a potent modulator of
synapses throughout the CNS.50,51 Thus, higher numbers of
these cell-types resulting in greater BDNF secretion could
contribute to increased synaptic density. Another important
consideration is the fact that retinal glia do not act in isolation,
but are perpetually engaged in a wide range of dynamic
interactions with other cell types. Therefore, it is possible that
the alterations in microglia and macrophages observed in our
experiments also induced changes in astrocytes and Mu¨ller
glia, which have important roles in regulating neuronal health.
FIGURE 5. (A, B) Optic nerve head sections showed higher numbers of Iba-1þ/CD45lo cells alone. *P < 0.05, **P < 0.01, ***P < 0.001.
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A deeper understanding of these cellular interactions would no
doubt be valuable in identifying potential pathways to protect
RGCs from glaucomatous injury.
The laser-induced ocular hypertension model has been
extensively used in previous studies and has the advantage of a
rapid and reliable elevation of IOP in most treated animals. The
clearly defined onset of injury in this model allows the time-
course of early pathologic changes in RGC after IOP elevation
to be studied. However, the model has several important
limitations relevant to the interpretation of the results of the
current study. Many of the eyes in the experimental group
were relasered after 1 week to increase the IOP
(Supplementary Fig. S1). The criterion for relasering was IOP
<20 mm Hg at 1 week and in this regard there was some
variation between groups. This issue potentially complicates
separation of the effects of laser-induced inflammation from
the effects of laser-induced IOP elevation. There also was some
variability in the rate of IOP increase and the duration of IOP
elevation in different animals. Although this variation did not
result in significant differences in cumulative IOP, previously
identified as the IOP parameter correlated most strongly with
RGC loss in the laser model,19,52 there was at least a trend
towards higher IOP at 1 week in PDGF-treated eyes which
should be taken into account when interpreting the results
since early exposure to higher IOP alone could have resulted in
greater microglial/monocytic recruitment and activation. It
also is possible that some differences in IOP profile between
groups could have been missed with the IOP measurement
time-points used. In future studies we plan to compare the
results in the laser model of ocular hypertension to other
models, including a microbead injection model of ocular
hypertension in which we expect induced inflammation to be
less of a confounding issue.53,54 Awake IOP measurements will
enable more frequent measurement of IOP and, thus, more
complete IOP profiles for individual animals.
To the best of our knowledge, this is the first study to
suggest that PDGF promotes synaptic density in the retina of
ocular hypertensive eyes. Further work must be done to
evaluate whether the increase in microglia and monocyte-
derived macrophage populations associated with PDGF treat-
ments are directly responsible for this effect, although current
literature would seem to support this hypothesis. Defining the
biological pathways that underlie synaptic changes occurring
in the initial stages of glaucoma would provide important
insights into the pathogenesis of this disease, and may lead to
potential opportunities for early therapeutic intervention.
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